Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 13868
Country/Region: Kenya
Year: 2018
Main Partner: New Partner
Main Partner Program: NA
Organizational Type: Unknown
Funding Agency: USAID
Total Funding: $2,302,684 Additional Pipeline Funding: $1,174,440

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $238,268
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $25,990
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $415,336
Sexual Prevention: Other Sexual Prevention (HVOP) $83,324
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $412,277
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $1,116,545
Treatment: Pediatric Treatment (PDTX) $10,944
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_SELF 2019 224
HTS_SELF 2019 649
HTS_SELF 15-19, Female, Directly-Assisted 2019 12
HTS_SELF 15-19, Female, Directly-Assisted 2019 34
HTS_SELF 15-19, Female, Unassisted 2019 12
HTS_SELF 15-19, Female, Unassisted 2019 34
HTS_SELF 15-19, Male, Directly-Assisted 2019 3
HTS_SELF 15-19, Male, Directly-Assisted 2019 10
HTS_SELF 15-19, Male, Unassisted 2019 3
HTS_SELF 15-19, Male, Unassisted 2019 10
HTS_SELF 20-24, Female, Directly-Assisted 2019 12
HTS_SELF 20-24, Female, Directly-Assisted 2019 34
HTS_SELF 20-24, Female, Unassisted 2019 12
HTS_SELF 20-24, Female, Unassisted 2019 34
HTS_SELF 20-24, Male, Directly-Assisted 2019 3
HTS_SELF 20-24, Male, Directly-Assisted 2019 10
HTS_SELF 20-24, Male, Unassisted 2019 3
HTS_SELF 20-24, Male, Unassisted 2019 10
HTS_SELF 25-29, Female, Directly-Assisted 2019 12
HTS_SELF 25-29, Female, Directly-Assisted 2019 34
HTS_SELF 25-29, Female, Unassisted 2019 12
HTS_SELF 25-29, Female, Unassisted 2019 34
HTS_SELF 25-29, Male, Directly-Assisted 2019 3
HTS_SELF 25-29, Male, Directly-Assisted 2019 10
HTS_SELF 25-29, Male, Unassisted 2019 3
HTS_SELF 25-29, Male, Unassisted 2019 10
HTS_SELF 30-34, Female, Directly-Assisted 2019 12
HTS_SELF 30-34, Female, Directly-Assisted 2019 34
HTS_SELF 30-34, Female, Unassisted 2019 12
HTS_SELF 30-34, Female, Unassisted 2019 34
HTS_SELF 30-34, Male, Directly-Assisted 2019 3
HTS_SELF 30-34, Male, Directly-Assisted 2019 10
HTS_SELF 30-34, Male, Unassisted 2019 3
HTS_SELF 30-34, Male, Unassisted 2019 10
HTS_SELF 35-39, Female, Directly-Assisted 2019 12
HTS_SELF 35-39, Female, Directly-Assisted 2019 34
HTS_SELF 35-39, Female, Unassisted 2019 12
HTS_SELF 35-39, Female, Unassisted 2019 34
HTS_SELF 35-39, Male, Directly-Assisted 2019 3
HTS_SELF 35-39, Male, Directly-Assisted 2019 10
HTS_SELF 35-39, Male, Unassisted 2019 3
HTS_SELF 35-39, Male, Unassisted 2019 10
HTS_SELF 40-49, Female, Directly-Assisted 2019 12
HTS_SELF 40-49, Female, Directly-Assisted 2019 34
HTS_SELF 40-49, Female, Unassisted 2019 12
HTS_SELF 40-49, Female, Unassisted 2019 34
HTS_SELF 40-49, Male, Directly-Assisted 2019 3
HTS_SELF 40-49, Male, Directly-Assisted 2019 10
HTS_SELF 40-49, Male, Unassisted 2019 3
HTS_SELF 40-49, Male, Unassisted 2019 10
HTS_SELF 50+, Female, Directly-Assisted 2019 12
HTS_SELF 50+, Female, Directly-Assisted 2019 34
HTS_SELF 50+, Female, Unassisted 2019 12
HTS_SELF 50+, Female, Unassisted 2019 34
HTS_SELF 50+, Male, Directly-Assisted 2019 3
HTS_SELF 50+, Male, Directly-Assisted 2019 10
HTS_SELF 50+, Male, Unassisted 2019 3
HTS_SELF 50+, Male, Unassisted 2019 10
HTS_SELF Directly-Assisted 2019 112
HTS_SELF Directly-Assisted 2019 325
HTS_SELF FSW, Directly-Assisted 2019 150
HTS_SELF FSW, Directly-Assisted 2019 435
HTS_SELF MSM, Directly-Assisted 2019 31
HTS_SELF MSM, Directly-Assisted 2019 99
HTS_SELF PWID, Directly-Assisted 2019 12
HTS_SELF PWID, Directly-Assisted 2019 39
HTS_SELF Unassisted 2019 112
HTS_SELF Unassisted 2019 324
HTS_SELF Unassisted - Other 2019 12
HTS_SELF Unassisted - Other 2019 32
HTS_SELF Unassisted - Self 2019 56
HTS_SELF Unassisted - Self 2019 163
HTS_SELF Unassisted - Sex Partner 2019 46
HTS_SELF Unassisted - Sex Partner 2019 130
HTS_TST 15-19, Female, Negative 2019 50
HTS_TST 15-19, Female, Negative 2019 66
HTS_TST 15-19, Male, Negative 2019 72
HTS_TST 15-19, Male, Negative 2019 54
HTS_TST 20-24, Female, Negative 2019 159
HTS_TST 20-24, Female, Negative 2019 254
HTS_TST 20-24, Male, Negative 2019 225
HTS_TST 20-24, Male, Negative 2019 183
HTS_TST 25-29, Female, Negative 2019 1,682
HTS_TST 25-29, Female, Negative 2019 1
HTS_TST 25-29, Female, Negative 2019 275
HTS_TST 25-29, Female, Negative 2019 2,694
HTS_TST 25-29, Female, Negative 2019 2,827
HTS_TST 25-29, Female, Negative 2019 116
HTS_TST 25-29, Female, Negative 2019 8
HTS_TST 25-29, Female, Negative 2019 2,149
HTS_TST 25-29, Female, Negative 2019 191
HTS_TST 25-29, Female, Negative 2019 1,901
HTS_TST 25-29, Female, Negative 2019 1,268
HTS_TST 25-29, Female, Negative 2019 58
HTS_TST 25-29, Female, Negative 2019 12
HTS_TST 25-29, Male, Negative 2019 908
HTS_TST 25-29, Male, Negative 2019 100
HTS_TST 25-29, Male, Negative 2019 123
HTS_TST 25-29, Male, Negative 2019 1,978
HTS_TST 25-29, Male, Negative 2019 19
HTS_TST 25-29, Male, Negative 2019 10
HTS_TST 25-29, Male, Negative 2019 558
HTS_TST 25-29, Male, Negative 2019 2
HTS_TST 25-29, Male, Negative 2019 274
HTS_TST 25-29, Male, Negative 2019 15
HTS_TST 25-29, Male, Negative 2019 3,960
HTS_TST 25-29, Male, Negative 2019 62
HTS_TST 25-29, Male, Negative 2019 15
HTS_TST 30-34, Female, Negative 2019 1,917
HTS_TST 30-34, Female, Negative 2019 1
HTS_TST 30-34, Female, Negative 2019 316
HTS_TST 30-34, Female, Negative 2019 2,959
HTS_TST 30-34, Female, Negative 2019 2,827
HTS_TST 30-34, Female, Negative 2019 137
HTS_TST 30-34, Female, Negative 2019 7
HTS_TST 30-34, Female, Negative 2019 2,454
HTS_TST 30-34, Female, Negative 2019 220
HTS_TST 30-34, Female, Negative 2019 2,125
HTS_TST 30-34, Female, Negative 2019 1,268
HTS_TST 30-34, Female, Negative 2019 69
HTS_TST 30-34, Female, Negative 2019 11
HTS_TST 30-34, Male, Negative 2019 1,088
HTS_TST 30-34, Male, Negative 2019 122
HTS_TST 30-34, Male, Negative 2019 2,436
HTS_TST 30-34, Male, Negative 2019 24
HTS_TST 30-34, Male, Negative 2019 11
HTS_TST 30-34, Male, Negative 2019 668
HTS_TST 30-34, Male, Negative 2019 2
HTS_TST 30-34, Male, Negative 2019 316
HTS_TST 30-34, Male, Negative 2019 18
HTS_TST 30-34, Male, Negative 2019 1
HTS_TST 30-34, Male, Negative 2019 4,766
HTS_TST 30-34, Male, Negative 2019 75
HTS_TST 30-34, Male, Negative 2019 17
HTS_TST 35-39, Female, Negative 2019 480
HTS_TST 35-39, Female, Negative 2019 75
HTS_TST 35-39, Female, Negative 2019 1,044
HTS_TST 35-39, Female, Negative 2019 2,827
HTS_TST 35-39, Female, Negative 2019 34
HTS_TST 35-39, Female, Negative 2019 9
HTS_TST 35-39, Female, Negative 2019 612
HTS_TST 35-39, Female, Negative 2019 56
HTS_TST 35-39, Female, Negative 2019 731
HTS_TST 35-39, Female, Negative 2019 1,268
HTS_TST 35-39, Female, Negative 2019 16
HTS_TST 35-39, Female, Negative 2019 13
HTS_TST 35-39, Male, Negative 2019 1,088
HTS_TST 35-39, Male, Negative 2019 122
HTS_TST 35-39, Male, Negative 2019 1,217
HTS_TST 35-39, Male, Negative 2019 24
HTS_TST 35-39, Male, Negative 2019 15
HTS_TST 35-39, Male, Negative 2019 668
HTS_TST 35-39, Male, Negative 2019 2
HTS_TST 35-39, Male, Negative 2019 326
HTS_TST 35-39, Male, Negative 2019 18
HTS_TST 35-39, Male, Negative 2019 1
HTS_TST 35-39, Male, Negative 2019 3,967
HTS_TST 35-39, Male, Negative 2019 75
HTS_TST 35-39, Male, Negative 2019 24
HTS_TST 40-49, Female, Negative 2019 480
HTS_TST 40-49, Female, Negative 2019 75
HTS_TST 40-49, Female, Negative 2019 1,044
HTS_TST 40-49, Female, Negative 2019 2,827
HTS_TST 40-49, Female, Negative 2019 34
HTS_TST 40-49, Female, Negative 2019 7
HTS_TST 40-49, Female, Negative 2019 612
HTS_TST 40-49, Female, Negative 2019 56
HTS_TST 40-49, Female, Negative 2019 731
HTS_TST 40-49, Female, Negative 2019 1,268
HTS_TST 40-49, Female, Negative 2019 16
HTS_TST 40-49, Female, Negative 2019 10
HTS_TST 40-49, Male, Negative 2019 22
HTS_TST 40-49, Male, Negative 2019 364
HTS_TST 40-49, Male, Negative 2019 39
HTS_TST 40-49, Male, Negative 2019 405
HTS_TST 40-49, Male, Negative 2019 5
HTS_TST 40-49, Male, Negative 2019 14
HTS_TST 40-49, Male, Negative 2019 221
HTS_TST 40-49, Male, Negative 2019 1
HTS_TST 40-49, Male, Negative 2019 109
HTS_TST 40-49, Male, Negative 2019 6
HTS_TST 40-49, Male, Negative 2019 1,321
HTS_TST 40-49, Male, Negative 2019 22
HTS_TST 50+, Female, Negative 2019 17
HTS_TST 50+, Female, Negative 2019 7
HTS_TST 50+, Male, Negative 2019 3
HTS_TST 50+, Male, Negative 2019 10
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 84,074
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 77,299
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 1
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 1
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 4
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 7
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 14
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 23
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 3
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2019 14
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2019 10
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 1,185
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 1,712
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 3,045
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 6,872
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2019 2
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2019 33
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2019 3
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 11
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 2
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 2
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 1
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 2
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 2
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 2
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 1
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 8
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 1
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 8
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 1
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2019 11
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2019 2
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 49
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 9
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 10
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 5
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 6
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 3
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 269
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 296
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 379
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 187
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 927
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 1,016
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 1,215
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 598
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 27
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 39
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 54
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 19
HTS_TST Service Delivery Point (Facility) Other PITC: <1, Negative 2019 77
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 346
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 288
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 89
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 131
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 49
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 99
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 2,561
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 1,545
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 4,025
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 2,237
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 12,165
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 6,979
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 9,772
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 5,612
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 363
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 520
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 660
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 201
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 27
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2019 7
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2019 4
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2019 9
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2019 5
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2019 8
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2019 4
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 13
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 9
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 15
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 10
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 13
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 9
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 15
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 10
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 10
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 7
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 18
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 11
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2019 16
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2019 29
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2019 57
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2019 183
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 45
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 21
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 17
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 15
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 976
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 1,743
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 882
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 821
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 3,374
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 6,001
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 2,836
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 2,631
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 238
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 307
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 113
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 180
HTS_TST Service Delivery Point (Facility) VMMC: 10-14, Negative 2019 123
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2019 185
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2019 185
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2019 58
HTS_TST_POS 20-24, Male, Positive 2019 1
HTS_TST_POS 25-29, Female, Positive 2019 47
HTS_TST_POS 25-29, Female, Positive 2019 7
HTS_TST_POS 25-29, Female, Positive 2019 68
HTS_TST_POS 25-29, Female, Positive 2019 149
HTS_TST_POS 25-29, Female, Positive 2019 1
HTS_TST_POS 25-29, Female, Positive 2019 47
HTS_TST_POS 25-29, Female, Positive 2019 3
HTS_TST_POS 25-29, Female, Positive 2019 42
HTS_TST_POS 25-29, Female, Positive 2019 56
HTS_TST_POS 25-29, Male, Positive 2019 19
HTS_TST_POS 25-29, Male, Positive 2019 7
HTS_TST_POS 25-29, Male, Positive 2019 54
HTS_TST_POS 25-29, Male, Positive 2019 1
HTS_TST_POS 25-29, Male, Positive 2019 16
HTS_TST_POS 25-29, Male, Positive 2019 1
HTS_TST_POS 25-29, Male, Positive 2019 3
HTS_TST_POS 25-29, Male, Positive 2019 97
HTS_TST_POS 30-34, Female, Positive 2019 53
HTS_TST_POS 30-34, Female, Positive 2019 8
HTS_TST_POS 30-34, Female, Positive 2019 73
HTS_TST_POS 30-34, Female, Positive 2019 27
HTS_TST_POS 30-34, Female, Positive 2019 1
HTS_TST_POS 30-34, Female, Positive 2019 53
HTS_TST_POS 30-34, Female, Positive 2019 4
HTS_TST_POS 30-34, Female, Positive 2019 46
HTS_TST_POS 30-34, Female, Positive 2019 8
HTS_TST_POS 30-34, Male, Positive 2019 25
HTS_TST_POS 30-34, Male, Positive 2019 7
HTS_TST_POS 30-34, Male, Positive 2019 67
HTS_TST_POS 30-34, Male, Positive 2019 1
HTS_TST_POS 30-34, Male, Positive 2019 18
HTS_TST_POS 30-34, Male, Positive 2019 1
HTS_TST_POS 30-34, Male, Positive 2019 5
HTS_TST_POS 30-34, Male, Positive 2019 118
HTS_TST_POS 35-39, Female, Positive 2019 13
HTS_TST_POS 35-39, Female, Positive 2019 2
HTS_TST_POS 35-39, Female, Positive 2019 27
HTS_TST_POS 35-39, Female, Positive 2019 22
HTS_TST_POS 35-39, Female, Positive 2019 1
HTS_TST_POS 35-39, Female, Positive 2019 14
HTS_TST_POS 35-39, Female, Positive 2019 1
HTS_TST_POS 35-39, Female, Positive 2019 18
HTS_TST_POS 35-39, Female, Positive 2019 7
HTS_TST_POS 35-39, Male, Positive 2019 25
HTS_TST_POS 35-39, Male, Positive 2019 7
HTS_TST_POS 35-39, Male, Positive 2019 31
HTS_TST_POS 35-39, Male, Positive 2019 1
HTS_TST_POS 35-39, Male, Positive 2019 18
HTS_TST_POS 35-39, Male, Positive 2019 1
HTS_TST_POS 35-39, Male, Positive 2019 5
HTS_TST_POS 35-39, Male, Positive 2019 95
HTS_TST_POS 40-49, Female, Positive 2019 13
HTS_TST_POS 40-49, Female, Positive 2019 2
HTS_TST_POS 40-49, Female, Positive 2019 27
HTS_TST_POS 40-49, Female, Positive 2019 13
HTS_TST_POS 40-49, Female, Positive 2019 1
HTS_TST_POS 40-49, Female, Positive 2019 13
HTS_TST_POS 40-49, Female, Positive 2019 1
HTS_TST_POS 40-49, Female, Positive 2019 18
HTS_TST_POS 40-49, Female, Positive 2019 3
HTS_TST_POS 40-49, Male, Positive 2019 6
HTS_TST_POS 40-49, Male, Positive 2019 9
HTS_TST_POS 40-49, Male, Positive 2019 1
HTS_TST_POS 40-49, Male, Positive 2019 4
HTS_TST_POS 40-49, Male, Positive 2019 1
HTS_TST_POS 40-49, Male, Positive 2019 26
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 7
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 11
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 32
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 90
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 12
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 18
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 39
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 22
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 20
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2019 7
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 51
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 20
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 16
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 73
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 35
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 106
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 65
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 337
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 158
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 262
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 170
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 7
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 21
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 46
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 26
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 31
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 82
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 160
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 83
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 98
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 3
PMTCT_ART Already on ART at beginning of current pregnancy 2019 254
PMTCT_ART New on ART 2019 313
PMTCT_ART New on ART 2019 102
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 567
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 102
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 23,092
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 5,259
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 15
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 15
PMTCT_EID Sum of Infant Age disaggregates 2019 15
PMTCT_STAT 25-29, Female 2019 3,335
PMTCT_STAT 25-29, Female 2019 687
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 56
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 4
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 3,232
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 668
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 46
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 15
PMTCT_STAT 30-34, Female 2019 3,335
PMTCT_STAT 30-34, Female 2019 687
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 56
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 4
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 3,232
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 668
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 46
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 15
PMTCT_STAT 35-39, Female 2019 3,335
PMTCT_STAT 35-39, Female 2019 687
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 56
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 4
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 3,232
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 668
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 46
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 15
PMTCT_STAT 40-49, Female 2019 3,335
PMTCT_STAT 40-49, Female 2019 687
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 56
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 4
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 3,232
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 668
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 46
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 15
PMTCT_STAT By Age (Numerator): : 15-19 2019 692
PMTCT_STAT By Age (Numerator): 10-14 2019 12
PMTCT_STAT By Age (Numerator): 10-14 2019 11
PMTCT_STAT By Age (Numerator): 15-19 2019 1,889
PMTCT_STAT By Age (Numerator): 20-24 2019 7,807
PMTCT_STAT By Age (Numerator): 20-24 2019 1,702
PMTCT_STAT By Age (Numerator): 50+ 2019 35
PMTCT_STAT By Age (Numerator): 50+ 2019 2
PMTCT_STAT By known positives: 20-24 2019 6
PMTCT_STAT By new negatives: 10-14 2019 11
PMTCT_STAT By new negatives: 15-19 2019 679
PMTCT_STAT By new negatives: 20-24 2019 1,660
PMTCT_STAT By new negatives: 50+ 2019 2
PMTCT_STAT By new positives: 15-19 2019 12
PMTCT_STAT By new positives: 20-24 2019 35
PMTCT_STAT By Number of known positives: 15-19 2019 6
PMTCT_STAT By Number of known positives: 20-24 2019 58
PMTCT_STAT By Number of new negative: 10-14 2019 12
PMTCT_STAT By Number of new negative: 15-19 2019 1,852
PMTCT_STAT By Number of new negative: 20-24 2019 7,635
PMTCT_STAT By Number of new negative: 50+ 2019 34
PMTCT_STAT By Number of new positives: 15-19 2019 30
PMTCT_STAT By Number of new positives: 20-24 2019 110
PMTCT_STAT Number of new ANC and L&D clients 2019 27,838
PMTCT_STAT Number of new ANC and L&D clients 2019 5,228
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 23,092
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 5,259
PMTCT_STAT_den 25-29, Female 2019 3,938
PMTCT_STAT_den 25-29, Female 2019 665
PMTCT_STAT_den 30-34, Female 2019 3,938
PMTCT_STAT_den 30-34, Female 2019 665
PMTCT_STAT_den 35-39, Female 2019 3,938
PMTCT_STAT_den 35-39, Female 2019 665
PMTCT_STAT_den 40-49, Female 2019 3,938
PMTCT_STAT_den 40-49, Female 2019 665
PMTCT_STAT_den By Age (Denominator): <15-19 2019 2,445
PMTCT_STAT_den By Age (Denominator): 10-14 2019 29
PMTCT_STAT_den By Age (Denominator): 10-14 2019 4
PMTCT_STAT_den By Age (Denominator): 15-19 2019 684
PMTCT_STAT_den By Age (Denominator): 20-24 2019 9,433
PMTCT_STAT_den By Age (Denominator): 20-24 2019 1,875
PMTCT_STAT_den By Age (Denominator): 50+ 2019 179
PMTCT_STAT_den By Age (Denominator): 50+ 2019 5
PrEP_NEW 25-29, Female 2019 14
PrEP_NEW 25-29, Male 2019 6
PrEP_NEW 30-34, Female 2019 12
PrEP_NEW 30-34, Male 2019 8
PrEP_NEW 35-39, Female 2019 12
PrEP_NEW 35-39, Male 2019 8
PrEP_NEW 40-49, Female 2019 12
PrEP_NEW 40-49, Male 2019 6
PrEP_NEW Female 15-19 2019 25
PrEP_NEW Female 20-24 2019 92
PrEP_NEW Female 50+ 2019 4
PrEP_NEW FSW 2019 31
PrEP_NEW Male 15-19 2019 2
PrEP_NEW Male 20-24 2019 14
PrEP_NEW Male 50+ 2019 4
PrEP_NEW MSM 2019 14
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2019 225
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 44
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 71
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 115
TB_PREV By Age/Sex (Numerator): <15, Female 2019 31
TB_PREV By Age/Sex (Numerator): <15, Male 2019 32
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 555
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 221
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 838
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 581
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 23
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 20
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 369
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 166
TB_PREV_den IPT, Life-long ART, New, Positive 2019 581
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 9
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 2
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 98
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 10
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 1
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 159
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 271
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 3
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 278
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period. 2019 3
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 9
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 2
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 98
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 9
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 1
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 167
TX_CURR 25-29, Female, Positive 2019 1,304
TX_CURR 25-29, Male, Positive 2019 369
TX_CURR 30-34, Female, Positive 2019 940
TX_CURR 30-34, Male, Positive 2019 571
TX_CURR 35-39, Female, Positive 2019 940
TX_CURR 35-39, Male, Positive 2019 571
TX_CURR 40-49, Female, Positive 2019 636
TX_CURR 40-49, Male, Positive 2019 571
TX_CURR Age/Sex: <1-9 2019 66
TX_CURR Age/Sex: 10-14 Female 2019 39
TX_CURR Age/Sex: 10-14 Male 2019 29
TX_CURR Age/Sex: 15-19 Female 2019 187
TX_CURR Age/Sex: 15-19 Male 2019 108
TX_CURR Age/Sex: 20-24 Female 2019 551
TX_CURR Age/Sex: 20-24 Male 2019 139
TX_CURR Age/Sex: 50+ Female 2019 516
TX_CURR Age/Sex: 50+ Male 2019 219
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 7,816
TX_CURR Sum of age/sex disaggregates 2019 295
TX_NEW 25-29, Female, Positive 2019 14
TX_NEW 25-29, Male, Positive 2019 110
TX_NEW 30-34, Female, Positive 2019 18
TX_NEW 30-34, Male, Positive 2019 129
TX_NEW 35-39, Female, Positive 2019 2
TX_NEW 35-39, Male, Positive 2019 128
TX_NEW 40-49, Female, Positive 2019 2
TX_NEW 40-49, Male, Positive 2019 34
TX_NEW Breastfeeding status 2019 15
TX_NEW By Age/Sex: <1 2019 8
TX_NEW By Age/Sex: 1-9 2019 7
TX_NEW By Age/Sex: 10-14 Female 2019 1
TX_NEW By Age/Sex: 15-19 Female 2019 137
TX_NEW By Age/Sex: 15-19 Male 2019 141
TX_NEW By Age/Sex: 20-24 Female 2019 484
TX_NEW By Age/Sex: 20-24 Male 2019 479
TX_NEW By Age/Sex: 50+ Male 2019 10
TX_NEW FSW 2019 15
TX_NEW MSM 2019 7
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 1,754
TX_NEW People in prisons and other enclosed settings 2019 16
TX_NEW Pregnancy status 2019 144
TX_NEW Sum of Age/Sex disaggregates 2019 1,252
TX_NEW TG 2019 1
TX_PVLS 15+, Undocumented Test Indication, Female 2019 36
TX_PVLS 15+, Undocumented Test Indication, Male 2019 46
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 5,194
TX_PVLS Undocumented Test Indication 2019 82
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 45
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2019 4
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 15
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 2,982
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2019 51
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 1,701
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2019 43
TX_PVLS_den Denominator: Indication: Routine 2019 4,562
TX_PVLS_den Denominator: Indication: Targeted 2019 53
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 2
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 1,173
TX_RET Numerator by Status: Breastfeeding 2019 12
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 1,571
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 1,024
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 504
TX_RET_den Denominator by Status: Breastfeeding 2019 19
TX_RET_den Denominator by Status: Pregnant 2019 124
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 7,816
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 297
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 287
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 4,696
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 2,537
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 192
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 42
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 249
Cross Cutting Budget Categories and Known Amounts Total: $439,654
Condoms: Policy, Tools, and Services $439,654